Littleton, MA, United States of America

Dominic Ryan

This inventor holds 1 USPTO granted patent. Top assignee: Cubist Pharmaceuticals, Incorporated. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dominic Ryan. Retrieved from https://idiyas.com/inventor/dominic-ryan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Dominic Ryan

Introduction

Dominic Ryan is a notable inventor based in Littleton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. His work focuses on the inhibition of the TRPA1 ion channel, which is associated with various medical conditions.

Latest Patents

Dominic holds 1 patent for his invention titled "Inhibiting transient receptor potential ion channel TRPA1." This patent describes novel compounds and pharmaceutical compositions aimed at inhibiting the TRPA1 ion channel. The implications of this work are particularly relevant for treating medical conditions related to TRPA1, such as pain.

Career Highlights

Dominic is currently employed at Cubist Pharmaceuticals, Incorporated, where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in ion channel inhibition has positioned him as a valuable asset in the field.

Collaborations

Dominic has collaborated with notable colleagues, including Chester A Metcalf, III and Yu Gui Gu. These partnerships have further enhanced his research and development efforts.

Conclusion

Dominic Ryan's contributions to the field of pharmaceuticals, particularly through his patent on TRPA1 inhibition, highlight his innovative spirit and dedication to improving pain management solutions. His work at Cubist Pharmaceuticals continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…